SecBot SecBot
S-1/A ·Filed Oct 28, 2026
NU

NUOX

NuvOx Therapeutics, Inc.
NEUTRAL
Impact 5/10
Processed15h 33m ago SEC0001213900-26-113463
IPO registration amendment

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
S-1/A Filing (Primary)0001213900-26-113463
Document: ea022525714ex-fee.htm0001213900-26-113463
Document: ea022525714ex23-1.htm0001213900-26-113463
Document: 0001213900-26-113463-index-headers.html0001213900-26-113463
Document: 0001213900-26-113463-index.html0001213900-26-113463
Document: 0001213900-26-113463.txt0001213900-26-113463
3 reports for NUOX
Performance horizon
Filters
Rows
Reports for NUOX, sortable and filterable
TypeNow
Oct 28, 2026
today
S-1/A
NEUTRAL ★ 5/10
No priceawaiting T+20awaiting T+20No price
Oct 9, 2026
20d ago
S-1/A
NEUTRAL ★ 5/10
No priceawaiting T+20awaiting T+20No price
Sep 16, 2026
6w ago
S-1/A
NEUTRAL ★ 5/10
No priceawaiting T+20awaiting T+20No price
Showing 3 of 3

US Market Status

Market Closed · Opens Mon (59h 53m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 29, 2026

Fresh NUOX Intelligence

Analysis is for subscribers only.

Subscribe for Full Access